This important study provides solid in-vivo evidence that CCR4 regulates the early inflammatory response during atherosclerotic plaque formation. The authors propose that altered T-cell response plays ...
with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes. The clinical trial is open for enrollment and will include PID patients with ALPS-FAS, CTLA4 haploinsufficiency ...